Source: Pharmacy Times articles
Amid intensified scrutiny of COVID-19 vaccines at HHS, Moderna’s mRNA-1283 COVID-19 vaccine was granted FDA approval, for patients 65 years and older and patients aged 12 to 64 years with at least 1 or more underlying risk for severe COVID-19.
Read More